Description
Palboxen (Palbociclib) 125mg 21 Capsules – Everest Pharmaceuticals
Palboxen (Palbociclib) 125mg is a prescription-only anticancer medicine manufactured by Everest Pharmaceuticals Ltd., Bangladesh. It is primarily used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer in postmenopausal women.
Belonging to the class of cyclin-dependent kinase (CDK) 4/6 inhibitors, Palboxen works by blocking proteins that promote cell division, thereby slowing down or stopping the growth of cancer cells.
Key Features
-
Brand Name: Palboxen
-
Generic Name: Palbociclib
-
Strength: 125mg
-
Pack Size: 21 capsules
-
Manufacturer: Everest Pharmaceuticals Ltd. (Bangladesh)
-
Therapeutic Class: CDK4/6 Inhibitor – Anticancer Medicine
Indications (Uses)
Palboxen 125mg is indicated for the treatment of:
-
HR+/HER2- advanced or metastatic breast cancer in postmenopausal women.
-
Used in combination with hormone therapies such as aromatase inhibitors or fulvestrant.
Dosage & Administration
-
Recommended dose: 125mg once daily with food.
-
Take for 21 consecutive days, followed by a 7-day break (one 28-day cycle).
-
Dosage should only be adjusted or continued under the supervision of an oncologist.
Mechanism of Action
-
Palbociclib selectively inhibits CDK4 and CDK6, proteins responsible for cell cycle progression.
-
By blocking these enzymes, it prevents cancer cells from multiplying and helps slow tumor growth.
Possible Side Effects
Common side effects may include:
-
Nausea and vomiting
-
Fatigue and weakness
-
Diarrhea or loss of appetite
-
Hair thinning or hair loss
-
Mouth sores (stomatitis)
⚠️ Serious side effects such as low white blood cell count (neutropenia) may occur, requiring regular blood tests.
Packaging Information
-
Form: Oral capsules
-
Strength: 125mg
-
Pack: Bottle containing 21 capsules
Storage Instructions
-
Store at room temperature (below 30°C) in a dry place.
-
Keep away from direct sunlight, moisture, and out of reach of children.
Disclaimer
Palboxen (Palbociclib) 125mg is a prescription medication. It should be taken strictly under the guidance of a qualified oncologist. This information is intended for educational purposes only and should not replace professional medical advice.
Reviews
There are no reviews yet.